Dan Theodorescu

Dr Dan Theodorescu is an academic and a professor of Surgery-Urology at the University of Colorado. His research is focused on bladder cancer.[1] He is the director for the National Cancer Institute (NCI) at the university.[2][3][4]

Publications
  • RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer, Jan 2018[5]
  • Precision medicine for urothelial bladder cancer: update on tumor genomics and immunotherapy, Feb 2018[6]

References
  1. "Faculty Profile | School of Medicine | University of Colorado Denver". som.ucdenver.edu. Retrieved 2020-10-23.
  2. "Dan Theodorescu, MD, Ph.D." GoldLab Foundation. Retrieved 2020-10-23.
  3. "Dan Theodorescu, MD, PhD". Bladder Cancer Advocacy Network. Retrieved 2020-10-23.
  4. "Join me in supporting The Campaign for Cedars-Sinai #CedarsGratitude". #CedarsGratitude. Retrieved 2020-10-23.
  5. Yan, Chao; Theodorescu, Dan (2018). "RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer". Pharmacological Reviews. 70 (1): 1–11. doi:10.1124/pr.117.014415. ISSN 1521-0081. PMC 5712631. PMID 29196555.
  6. Felsenstein, Kenneth M.; Theodorescu, Dan (2018). "Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy". Nature Reviews. Urology. 15 (2): 92–111. doi:10.1038/nrurol.2017.179. ISSN 1759-4820. PMID 29133939. S2CID 3020749.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.